FAM167A: A Potential Drug Target and Biomarker (G83648)

Target Name: FAM167A

NCBI ID: G83648

FAM167A

FAM167A: A Potential Drug Target and Biomarker

The FAM167A gene is a member of the family with sequence similarity 167 (FAM167) and is located on chromosome 6p12.3. It is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The FAM167A gene is a member of the FAM167 family, which is characterized by the presence of a characteristic domain called the FAM167 domain. This domain is composed of 114 amino acid residues and is located between the 11th and 12th amino acid positions on the protein sequence. The FAM167 domain is known for its ability to form a highly stable complex with small molecules, such as drugs, leading to the potential for drug targeting.

FAM167A has been shown to be involved in various cellular processes, including cell adhesion, migration, and the regulation of ion channels. It has also been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of the FAM167A gene is its potential as a drug target. The FAM167A domain has been shown to be highly stable and to be involved in the formation of drug-like compounds that are capable of interacting with the FAM167A protein. This suggests that drugs that can bind to the FAM167A protein could be effective in treating diseases associated with this protein.

In addition to its potential as a drug target, the FAM167A gene has also been identified as a potential biomarker for various diseases. The FAM167A protein is expressed in many different tissues and cells, including cancer cells, neurons, and immune cells. This makes it a potential source of biomarkers for these diseases. Additionally, the FAM167A gene has been shown to be involved in the regulation of cellular processes, including cell adhesion and the regulation of ion channels. This suggests that changes in the FAM167A gene expression levels could be a potential biomarker for certain diseases.

In conclusion, the FAM167A gene is a member of the family with sequence similarity 167 and has been shown to be involved in various cellular processes and to be involved in the development and progression of various diseases. Its potential as a drug target or biomarker makes it an attractive target for future research. Further studies are needed to fully understand the role of the FAM167A gene in disease and to develop effective treatments.

Protein Name: Family With Sequence Similarity 167 Member A

The "FAM167A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM167A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets